Medicare enrollees will see average monthly premiums for stand-alone prescription drug plans jump 50% to $51 in 2027. The increase outpaces prior federal projections and impacts millions of beneficiaries across the United States. Rising out-of-pocket expenses come as the administration ends a federal subsidy program for insurers.
